Skip to main content

Tomorrow Investor

The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares

Precision Peptide Company Secures $2 Million in LIFE Offering | Newsfile Corp

Vancouver, British Columbia–(Newsfile Corp. – July 15, 2026) – The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the “Company” or “BPC”), is pleased to announce that further to its news release dated June 11, 2026, it has closed its previously announced non-brokered private placement of common shares in the capital of the Company (the “Shares”) at a price of $0.50 per Share under the Listed Issuer Financing Exemption (as defined herein) for gross proceeds of $2,000,000 (the “LIFE Offering”) through the issuance of 4,000,000 Shares. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), the LIFE Offering was made to purchasers resident in all provinces of Canada, except Quebec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the “Listed Issuer Financing Exemption”).

This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.

Brief Summary

The Precision Peptide Company (CSE: BPC) has successfully completed a non-brokered private placement, raising $2,000,000 through the issuance of 4,000,000 common shares at a price of $0.50 each. This initiative is in compliance with relevant regulatory frameworks and highlights strong investor confidence in BPC’s future potential.

  • Gross Proceeds: $2,000,000
  • Shares Issued: 4,000,000
  • Price per Share: $0.50
  • Exemption: Listed Issuer Financing Exemption
  • Target Market: All provinces in Canada (except Quebec)

Why it matters: This capital infusion will enable The Precision Peptide Company to fuel growth initiatives, strengthen its market position, and enhance shareholder value.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.